Cholesterol efflux capacity is an independent predictor of all-cause and cardiovascular mortality in patients with coronary artery disease: A prospective cohort study

Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond

Michael J. Pencina, Ralph B. D' Agostino, Ralph B. D' Agostino et al. · Statistics in Medicine · 2007 · 6.3K citations · Full text

Medicine, Biostatistics, Cardiology +17

ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction: Executive Summary and Recommendations

Eugene Braunwald, Elliott M. Antman, John W. Beasley et al. · Circulation · 2000 · 4.5K citations · Full text

Medicine, Cardiology, Internal Medicine +14

ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

Željko Reiner, Alberico L. Catapano, Guy De Backer et al. · European Heart Journal · 2011 · 3.5K citations · Full text

Medicine, Cardiology, Internal Medicine +17

Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

Gregory G. Schwartz, Anders Olsson, Markus Abt et al. · New England Journal of Medicine · 2012 · 2K citations · Full text

Medicine, Cardiology, Pharmacology +17

Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis

Amit Khera, Marina Cuchel, Margarita de la Llera-Moya et al. · New England Journal of Medicine · 2011 · 1.9K citations · Full text

Life Sciences, Biochemistry, Physiology +13